FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer
Immune cells are known to affect clinical outcome in colorectal cancer. Subsets of immune cells can both support and inhibit immunological interaction with tumor cells. We examined the clinical impact of T cells that are supposed to be responsible for the down regulation of a T cell response: regula...
Main Authors: | Zeestraten, Eliane C. M., Van Hoesel, Anneke Q., Speetjens, Frank M., Menon, Anand G., Putter, Hein, van de Velde, Cornelis J. H., Kuppen, Peter J. K. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Netherlands
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601218/ |
Similar Items
-
Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer
by: Benard, Anne, et al.
Published: (2014) -
Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer
by: Benard, Anne, et al.
Published: (2014) -
Biomarkers in precision therapy in colorectal cancer
by: Reimers, Marlies S., et al.
Published: (2013) -
FoxP3 gets a new gig
by: Van Epps, Heather L.
Published: (2005) -
The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by Immunohistochemistry
by: Zeestraten, Eliane C.M., et al.
Published: (2013)